INS and glucose metabolism disease: Furthermore, the glucose metabolism disorder group had significantly higher FBG (4.97 [4.54–5.51] vs 4.69 [4.35–5.00] mmol/L, P < .001), FBI (21.47 [15.22–34.10] vs 18.60 [13.04–26.51] μIU/mL, P < .001), HOMA-IR (4.87 [3.43–7.60] vs 3.84 [2.66–5.50], P < .001), HbA1c (5.20% [4.80–5.60%] vs 5.03% [4.68–5.49%], P = .001), OGTT 2-hour blood glucose level (8.30 [7.91–9.15] vs 6.60 [6.03–7.14] mmol/L, P < .001) and OGTT 2-hour blood insulin level (165.45 [20.61–333.90] vs 89.48 [7.03–382.4] μIU/mL, P < .001).